HA
Therapeutic Areas
Early Is Good Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BCDx Monitoring | Bladder Cancer — Recurrence Monitoring (Active Surveillance) | Clinical Validation |
| BCDx Detect | Bladder Cancer — Early Detection (Initial Diagnosis) | Clinical Development |
| PCDx | Prostate Cancer — Screening & Risk Stratification | R&D / Early Clinical |
Leadership Team at Early Is Good
TL
Thakshila Liyanage, PhD
Co-Founder & CEO
AA
Asel Ananda, MSc
Co-Founder & CTO
CP
Chamath Palihapitiya
Director (Social Capital)
HK
Hristos Kaimakliotis, MD
Clinical Advisor
CD
Clinton D. Bahler, MD
Clinical Advisor
SG
Saum Ghodoussipour, MD
Clinical Advisor
EP
Emanuel Petricoin, PhD
Scientific Advisor
VW
Vince Wong
Advisor